CIPHEROME INC has a total of 21 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, EPO (European Patent Office) and Republic of Korea. Its main competitors in its focus markets computer technology, biotechnology and environmental technology are PERSONALIS INC, GENPROFILE AG and GREEN CROSS GENOME CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Republic of Korea | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 4 | |
#5 | China | 3 |
# | Industry | |
---|---|---|
#1 | Computer technology | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Pharmaceuticals | |
#5 | Audio-visual technology |
# | Name | Total Patents |
---|---|---|
#1 | Kim Ju Han | 14 |
#2 | Lee Kye H | 5 |
#3 | Park Paul J | 5 |
#4 | Baik Su Yeon | 4 |
#5 | Lee Soo Youn | 4 |
#6 | Baik Su-Yeon | 2 |
#7 | Kim Ju-Han | 2 |
#8 | Lee Soo-Youn | 2 |
Publication | Filing date | Title |
---|---|---|
WO2017100794A1 | Computer-implemented evaluaton of drug safety for a population | |
US2018032664A1 | Method for selecting anticancer agent based on protein damage information of individual to prevent anticancer agent side effects | |
KR20160101706A | Method for personalized prevention of adverse drug reaction of tocolytics based on information of individual deleterious protein sequence variation | |
WO2016133375A1 | Method for selecting osteoporosis therapeutic agent based on protein damage information of individual to prevent osteoporosis therapeutic agent side effects |